VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MCRB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MCRBSeres Therapeutics, Inc.
$1.98$19M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMCRBQuarterly Balance Sheet

Seres Therapeutics, Inc. (MCRB) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Seres Therapeutics, Inc. (MCRB) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

MCRB Balance Sheet

Quarterly statement

MCRB Balance Sheet

Seres Therapeutics, Inc. (MCRB) balance sheet — 14-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets34.42M42.35M31.84M49.38M51.53M48.69M66.08M38.67M72.93M149.26M165.18M175.41M214.39M251.24M116.08M194.76M247.51M209.58M263.25M303.63M
Cash & Short-Term Investments17.53M15.59M29.83M45.77M47.64M45.38M58.85M30.79M66.82M71.23M111.18M127.97M169.91M229.52M106.54M181.34M233M195.79M248M290.71M
Cash Only17.53M15.59M29.83M45.77M47.64M45.38M58.85M30.79M66.82M71.23M111.18M127.97M169.91M229.52M94.84M163.03M205.4M126.82M153.19M180M
Short-Term Investments0000000000000011.7M18.31M27.61M68.97M94.81M110.7M
Accounts Receivable12.68M25.27M233K360K777K882K4.38M4.75M018.6M7.42M016.86M7.56M000000
Days Sales Outstanding2.94K1.58K74.54119.41217.42--------5.44------
Inventory00000000053M41.97M29.65M18.52M5.34M000000
Days Inventory Outstanding----------167.16--10.39------
Other Current Assets4.21M01.77M3.25M3.11M2.42M2.85M3.13M6.1M6.43M4.61M17.8M9.1M8.82M9.54M13.42M00012.92M
Total Non-Current Assets31.46M59.24M85.78M88.82M91.95M95.11M98.1M101.14M105.81M172.47M176.08M183.19M153.31M155.15M154.11M154.02M64.36M63.62M56.64M51.23M
Property, Plant & Equipment30.66M56.97M77.08M80.12M83.25M86.42M89.41M92.44M95.48M121.08M124.78M108.03M131.67M134.31M133.22M133.97M43.23M44.52M45.31M36.15M
Fixed Asset Turnover0.01x0.01x0.00x0.01x0.00x------0.00x-0.95x-0.00x0.01x0.08x0.03x0.04x0.22x
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments773K08.67M8.67M8.67M8.67M8.67M8.67M9.87M9.87M9.83M00000000495K
Other Non-Current Assets31K2.27M31K31K31K31K31K31K465K41.52M41.47M75.16M21.63M20.84M20.89M20.05M21.12M19.09M11.33M14.59M
Total Assets65.89M101.59M117.62M138.19M143.47M143.8M164.18M139.81M178.74M321.73M341.26M358.6M367.7M406.39M270.19M348.78M311.87M273.2M319.89M354.86M
Asset Turnover0.01x0.01x0.00x0.00x0.00x------0.00x-0.37x-0.00x0.00x0.01x0.00x0.00x0.02x
Asset Growth %-54.08%-29.35%-28.36%-1.16%-19.73%-55.3%-51.89%-61.01%-51.39%-20.83%26.3%2.81%17.9%48.75%-15.54%-1.71%-21.3%1.32%4.64%3.48%
Total Current Liabilities20.89M20.03M19.34M19.32M22.43M30.94M31.32M41.22M64.83M108.28M98.48M98.66M79.22M77.9M63.82M85.6M81.82M89.04M82.36M82.26M
Accounts Payable1.46M1.19M2.34M1.68M1.68M2.2M2.17M4.08M8.25M4.81M5.22M3.64M8.96M12.92M12.3M17.44M10.45M13.99M6.79M13.73M
Days Payables Outstanding253.14--261242.31117.6779.7160.62--20.68--24.5230.4327.76-21.5223.327.98
Short-Term Debt12.65M010.87M10.39M9.92M0000000000456K0000
Deferred Revenue (Current)0000000007.92M8.11M7.73M9.83M3.63M2.38M4.26M4.87M11.1M20.44M16.82M
Other Current Liabilities6.78M04.3M4.57M6.39M15.03M2.63M20.81M2.11M78.92M059.19M006.48M034.11M33.06M29.81M35.88M
Current Ratio1.65x2.11x1.65x2.56x2.30x1.57x2.11x0.94x1.12x1.38x1.68x1.78x2.71x3.23x1.82x2.28x3.03x2.35x3.20x3.69x
Quick Ratio1.65x2.11x1.65x2.56x2.30x1.57x2.11x0.94x1.12x0.89x1.25x1.48x2.47x3.16x1.82x2.28x3.03x2.35x3.20x3.69x
Cash Conversion Cycle--------------8.7------
Total Non-Current Liabilities23.64M47.02M71.78M74.65M77.35M79.91M82.39M84.8M89.99M300.52M302.52M304.8M303.6M305.88M254.25M252.41M162.46M161.1M156.57M141.09M
Long-Term Debt000000000102.49M102.01M101.54M101.14M100.74M51.23M50.59M50.86M50.63M50.44M24.64M
Capital Lease Obligations23.12M44.82M69.63M72.58M75.33M77.96M80.5M82.97M85.27M100.94M103.34M91.65M104.86M106.71M106.69M107.94M17.85M19.52M20.35M17.96M
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities514K2.21M2.14M2.08M2.01M1.95M1.9M1.84M4.72M1.73M1.81M16.24M2.54M3.5M1.49M1.44M961K943K3.91M11.49M
Total Liabilities44.53M67.05M91.12M93.97M99.78M110.85M113.72M126.03M154.82M408.81M401M403.46M382.82M383.77M318.06M338M244.28M250.14M238.93M223.35M
Total Debt35.77M56.64M80.5M82.97M85.25M87.43M89.55M91.64M93.61M212.63M214.18M198.78M212.28M212.92M162.71M162.59M76.04M77.21M77.63M49.21M
Net Debt18.24M41.05M50.66M37.2M37.62M42.05M30.7M60.85M26.79M141.39M103M70.82M42.37M-16.6M67.87M-440K-129.36M-49.62M-75.56M-130.79M
Debt / Equity1.67x1.64x3.04x1.88x1.95x2.65x1.77x6.65x3.91x----9.42x-15.08x1.13x3.35x0.96x0.37x
Debt / EBITDA-------------4.17x------
Net Debt / EBITDA--------------0.33x------
Interest Coverage----------7.60x-6.92x-9.24x-10.22x15.54x-36.23x-36.33x-33.74x-42.19x-61.13x-66.98x
Total Equity21.36M34.53M26.5M44.22M43.7M32.95M50.47M13.78M23.92M-87.07M-59.74M-44.86M-15.12M22.61M-47.87M10.78M67.58M23.06M80.96M131.51M
Equity Growth %-51.12%4.81%-47.49%220.79%82.69%137.84%184.48%130.73%258.16%-485.04%-24.79%-515.99%-122.38%-1.93%-159.13%-91.8%-61.54%-77.19%-43.67%-24.75%
Book Value per Share2.143.582.774.994.983.775.790.090.16-11.49-8.18-6.94-2.363.48-7.611.7211.035.0017.5728.62
Total Shareholders' Equity21.36M34.53M26.5M44.22M43.7M32.95M50.47M13.78M23.92M-87.07M-59.74M-44.86M-15.12M22.61M-47.87M10.78M67.58M23.06M80.96M131.51M
Common Stock10K10K10K10K9K9K9K173K170K152K151K135K129K128K127K125K124K92K92K92K
Retained Earnings-1B-987.74M-992.32M-972.4M-957.07M-965.27M-945.42M-978.1M-962.46M-1.05B-1.02B-978.24M-936.99M-889.13M-935.68M-864.51M-795.72M-735.71M-670.98M-614.35M
Treasury Stock00000000000000000000
Accumulated OCI0000000000000-1K2K-12K-118K-256K-215K-60K
Minority Interest00000000000000000000